Center Lab.
晟德大藥廠股份有限公司
Center Lab. is a Taiwan TPEx-listed biotechnology company, as of 2026-11-01.
Pipeline
| Asset | Target / mechanism | Stage | Indication | Region | Source date | Source |
|---|---|---|---|---|---|---|
| CS02 | — | Phase 2; completed | T2DM With Inadequate Glycemic Control | Taiwan, United States | 2020-06-09 | Trial registry |
| R-verapamil | — | Phase 2; terminated | Episodic Cluster Headache | United Kingdom | 2018-04-11 | Trial registry |
Key events
No verified events in the past twelve months.